Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00055874
Status:
COMPLETED
Last Update Posted:
2018-05-03
First Post:
2003-03-06
Brief Title:
Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Sponsor:
Heidelberg University
Organization:
Heidelberg University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-06
Start Date Type:
None
Primary Completion Date:
2012-03-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03-31
Completion Date Type:
ACTUAL
First Submit Date:
2003-03-06
First Submit QC Date:
March 6 2003
Study First Post Date:
2003-03-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-02
Last Update Post Date:
2018-05-03
Last Update Post Date Type:
ACTUAL